Thursday, November 14, 2024
Home 2023

Yearly Archives: 2023

2022 Watch List

We’re Bearish, but we’re up 243% in Provention Bio (PRVB) Today.

Editor / Curator -
All News

Interview: Rokas Sidlauskas, Marketing Director of Society Pass (SOPA)

Editor / Curator -
Internet Stock Review, Biotech Stock Review, Roland Rick Perry
2023 Watch List

Unicycive Therapeutics (UNCY) $2.73 Tacks on Another 30%. We’re now up...

Editor / Curator -
Psychedelic News

Prince Harry Says Psychedelics Are a “Fundamental Part” of His Life...

Editor / Curator -
All News

Meet Dennis Nguyen CEO of Start-Up Investor, the Society Pass (Symbol:...

Editor / Curator -
All News

New Player in the Electric Vehicle (EV) Market?

Editor / Curator -
Fintech

Freedom Holding (FRHC) Acquires LD Micro From SRAX, Inc

Editor / Curator -
Unicycive
2022 Watch List

Unicycive (UNCY) Shoots and Scores, up 40% Today!

Editor / Curator -
Internet News

EyeOnChannel.com

Editor / Curator -
Biotech News

The Silent Killer: The Impact Of Kidney Disease On Patients And...

Editor / Curator -
1...141516...18Page 15 of 18

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.